No Data
No Data
Addus HomeCare Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Addus HomeCare(ADUS.US) With Buy Rating, Raises Target Price to $145
Express News | Addus Homecare Corp : Oppenheimer Raises Target Price to $145 From $140
Small Cap Stocks That Could Perform Best During 'Downturns' – BofA
Addus HomeCare Corporation (ADUS) Share Price Surged on Solid Result
Investing in Addus HomeCare (NASDAQ:ADUS) Five Years Ago Would Have Delivered You a 61% Gain
No Data
No Data